Consistent with that and a recent study (77), depletion of CD8+ T cells did not affect the survival rate of a-Egfl6 + a-PD-L1–treated ID8p53–/– Brca2–/– tumor bearing mice. This evidence concerns the gene EGFL6 and neoplasm.